{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:37:37Z","timestamp":1787315857026,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Topic:<\/jats:bold>\n                    Herpes simplex virus (HSV) and varicella zoster virus (VZV) are the most common ocular pathogens associated with infectious anterior uveitis. Currently, there are a number of antiviral agents administered to treat viral anterior uveitis (VAU). However, there is no consensus or guidelines about the most appropriate approach leading for the best treatment outcomes with fewer ocular complications.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Relevance:<\/jats:bold>\n                    To perform a systematic review and meta-analysis of the efficacy of different antiviral therapies in the management of anterior uveitis secondary to HSV and VZV.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We searched PubMed, Web of Science, CINAHL, OVID, and Embase up to January 2020. Randomized trials, non-randomized intervention studies, controlled before and after studies and observational studies assessing the effect of oral and or topical treatments for VAU were considered. Data extraction and analysis with evaluation of the risk of bias in the included trials were performed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Oral acyclovir demonstrated a statistically significant good treatment outcome in the management of VZV anterior uveitis (vs. placebo) (OR 0.26, 95% CI 0.11\u20130.59), but did not have similar effect in HSV anterior uveitis (OR 0.47, 95% CI 0.15\u20131.50). In the treatment of VZV anterior uveitis, there was significant superiority of oral acyclovir\u22127 day course\u2014over topical acyclovir (OR 4.17, 95% CI 1.28\u201313.52). Whereas, there was no significant superiority of one of the following treatment regimens over the others: topical acyclovir over topical corticosteroids (OR 1.86, 95% CI 0.67\u20135.17), and oral acyclovir\u22127 day course\u2014over oral acyclovir\u221214 day course\u2014(OR 0.21, 95% CI 0.01\u20134.50) or oral valaciclovir (OR 1.40, 95% CI 0.48\u20134.07).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Treatment of HSV and VZV anterior uveitis is currently based on individual experiences and limited literature, largely due to weak clinical trial evidence in this regard. Our results highlight the existence of a substantial gap in our evidence base. This finding might contribute to future research studies to ascertain the role of different antiviral therapies in the treatment of VAU.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Systematic Review Registration:<\/jats:bold>\n                    PROSPERO registration number: CRD420202 00404.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.686427","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:59:34Z","timestamp":1625187574000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-Induced Anterior Uveitis: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Ilaria","family":"Testi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng Xian","family":"Thng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Duggal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Kankaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Ling Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Paik","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pavesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/09273948.2018.1498109","article-title":"Review for disease of the year: treatment of viral anterior uveitis: a perspective","volume":"26","author":"Zandi","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"B2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0161-6420(00)00287-6","article-title":"Diagnosing and treating herpetic anterior uveitis","volume":"107","author":"Cunningham","year":"2000","journal-title":"Ophthalmology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00004397-200201000-00007","article-title":"Diagnosis and management of herpetic anterior uveitis","volume":"42","author":"Siverio J\u00fanior","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ICU.0b013e32834be021","article-title":"Viral anterior uveitis","volume":"22","author":"Jap","year":"2011","journal-title":"Curr Opin Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12886-016-0369-z","article-title":"Aqueous humor polymerase chain reaction in uveitis \u2013 utility and safety","volume":"16","author":"Chronopoulos","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1055\/s-2008-1034906","article-title":"Diagnosis of herpetic uveitis and keratouveitis","volume":"212","author":"Schacher","year":"1998","journal-title":"Klin Monatsbl Augenheilkd."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.2147\/OPTH.S93655","article-title":"Polymerase chain reaction in unilateral cases of presumed viral anterior uveitis","volume":"14","author":"Shoughy","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.4314\/ahs.v15i3.7","article-title":"Polymerase chain reaction to search for Herpes viruses in uveitic and healthy eyes: a South African perspective","volume":"15","author":"Laaks","year":"2015","journal-title":"Afr Health Sci. Sep."},{"key":"B9","first-page":"859","article-title":"Retinitis and deviant immune responses following intravitreal inoculation of HSV-1","volume":"28","author":"Atherton","year":"1987","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/OPTH.S60394","article-title":"Current aspects on the management of viral uveitis in immunocompetent individuals","volume":"5","author":"Pleyer","year":"2015","journal-title":"Clin Ophthalmol. Jun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0002-9394(86)90086-3","article-title":"Oral acyclovir in the treatment of acute herpes zoster ophthalmicus","volume":"102","author":"B\u00fcchi","year":"1986","journal-title":"Am J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/S0161-6420(85)33842-3","article-title":"Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report","volume":"92","author":"Cobo","year":"1985","journal-title":"Ophthalmology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0161-6420(86)33678-9","article-title":"Oral acyclovir in the treatment of acute herpes zoster ophthalmicus","volume":"93","author":"Cobo","year":"1986","journal-title":"Ophthalmology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","article-title":"Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus","volume":"107","author":"Colin","year":"2000","journal-title":"Ophthalmology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/02713689109020376","article-title":"Oral acyclovir in herpes zoster ophthalmicus","volume":"10","author":"Harding","year":"1991","journal-title":"Curr Eye Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0161-6420(92)31849-4","article-title":"Oral acyclovir for herpes zoster ophthalmicus","volume":"99","author":"Hoang-Xuan","year":"1992","journal-title":"Ophthalmology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/eye.1994.170","article-title":"Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus","volume":"8","author":"Neoh","year":"1994","journal-title":"Eye."},{"key":"B18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/bjo.75.9.542","article-title":"Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation","volume":"75","author":"Marsh","year":"1991","journal-title":"Br J Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bjo.67.11.746","article-title":"A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis","volume":"67","author":"McGill","year":"1983","journal-title":"Br J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archopht.1996.01100140267002","article-title":"A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1056\/NEJM199807303390510","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ajo.2007.06.001","article-title":"Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study","volume":"144","author":"Miserocchi","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/bjo.80.11.969","article-title":"Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis","volume":"80","author":"Wilhelmus","year":"1996","journal-title":"Br J Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/archopht.1997.01100150705001","article-title":"A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial","volume":"115","year":"1997","journal-title":"Arch Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","article-title":"Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus","volume":"36","author":"Szeto","year":"2017","journal-title":"Cornea."},{"key":"B26","first-page":"125","article-title":"Aciclovir et trifluorothymidine dans la k\u00e9rato-uv\u00e9ite herp\u00e9tique. Une \u00e9tude comparative en clinique humaine. Indications de la corticoth\u00e9rapie [Acyclovir and trifluorothymidine in herpetic kerato-uveitis. A comparative clinical study. Indications for corticoid therapy]","volume":"7","author":"Hoang-Xuan","year":"1984","journal-title":"J Fr Ophtalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"CD011503","DOI":"10.1002\/14651858.CD011503.pub2","article-title":"Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients","volume":"11","author":"Schuster","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.4103\/ijo.IJO_928_20","article-title":"Viral anterior uveitis","volume":"68","author":"Babu","year":"2020","journal-title":"Indian J Ophthalmol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.686427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T10:16:44Z","timestamp":1625221004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.686427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":28,"alternative-id":["10.3389\/fmed.2021.686427"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.686427","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"article-number":"686427"}}